Design, synthesis and biological evaluation of caudatin and its ester derivatives as novel antitumor agents

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Cancer Biology

Background:

• Caudatin, a natural product, serves as a scaffold for developing novel anti-cancer agents.
• Existing cancer therapies face challenges including drug resistance and toxicity.
• There is a continuous need for new chemotherapeutic compounds with improved efficacy.

Purpose of the Study:

• To synthesize and evaluate the anti-cancer potential of novel caudatin ester derivatives.
• To identify specific structural modifications that enhance anti-viability activity.
• To investigate the structure-activity relationships (SAR) of these derivatives.

Main Methods:

• Synthesis of a series of caudatin ester derivatives.
• In vitro anti-cancer activity screening against human lung (A549), prostate (PC3), liver (BEL-7402), and gastric (SGC-7901) cancer cell lines.
• Determination of half-maximal inhibitory concentrations (IC50) for active compounds.
• Structure-activity relationship analysis.

Main Results:

• All synthesized caudatin ester derivatives exhibited significant anti-cancer activities against the tested cell lines.
• The IC50 values of the derivatives were lower than that of the parent compound, caudatin.
• Compounds 5e and 5h demonstrated the most potent anti-viability effects.
• SAR studies indicated that modifications at the C3β position, such as introducing halogenated acyl or amino aryl groups, improved activity.
• Lipophilicity was identified as a key factor influencing the anti-viability activity.

Conclusions:

• Caudatin ester derivatives represent a promising class of anti-cancer compounds.
• Strategic modifications, particularly at the C3β position and modulation of lipophilicity, can significantly enhance anti-cancer efficacy.
• Further investigation into these derivatives may lead to the development of novel cancer therapeutics.